000 | 01927 a2200541 4500 | ||
---|---|---|---|
005 | 20250517144824.0 | ||
264 | 0 | _c20180716 | |
008 | 201807s 0 0 eng d | ||
022 | _a1699-5848 | ||
024 | 7 |
_a10.14670/HH-11-893 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aCui, Pingping | |
245 | 0 | 0 |
_aZoledronate promotes bone formation by blocking osteocyte-osteoblast communication during bone defect healing. _h[electronic resource] |
260 |
_bHistology and histopathology _cJan 2018 |
||
300 |
_a89-99 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdaptor Proteins, Signal Transducing |
650 | 0 | 4 |
_aAlkaline Phosphatase _xmetabolism |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBone Density Conservation Agents _xpharmacology |
650 | 0 | 4 |
_aCell Communication _xdrug effects |
650 | 0 | 4 |
_aConnexin 43 _xmetabolism |
650 | 0 | 4 |
_aDiphosphonates _xpharmacology |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 |
_aExtracellular Matrix Proteins _xmetabolism |
650 | 0 | 4 |
_aFemoral Fractures _xdrug therapy |
650 | 0 | 4 |
_aFracture Healing _xdrug effects |
650 | 0 | 4 |
_aGlycoproteins _xmetabolism |
650 | 0 | 4 |
_aImidazoles _xpharmacology |
650 | 0 | 4 | _aIntercellular Signaling Peptides and Proteins |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMice |
650 | 0 | 4 |
_aOsteoblasts _xdrug effects |
650 | 0 | 4 |
_aOsteoclasts _xdrug effects |
650 | 0 | 4 |
_aOsteocytes _xdrug effects |
650 | 0 | 4 |
_aOsteogenesis _xdrug effects |
650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
650 | 0 | 4 |
_aTartrate-Resistant Acid Phosphatase _xmetabolism |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 | _aZoledronic Acid |
700 | 1 | _aLiu, Hongrui | |
700 | 1 | _aSun, Jing | |
700 | 1 | _aAmizuka, Norio | |
700 | 1 | _aSun, Qinfeng | |
700 | 1 | _aLi, Minqi | |
773 | 0 |
_tHistology and histopathology _gvol. 33 _gno. 1 _gp. 89-99 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.14670/HH-11-893 _zAvailable from publisher's website |
999 |
_c27018164 _d27018164 |